UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 367

Sortiert nach

Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

The American heart journal, 2019-08, Vol.214, p.60-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Journal of the American College of Cardiology, 2014-11, Vol.64 (20), p.2101-2108

2014

Link zum Volltext

Verfügbarkeit prüfen

suPAR: A New Biomarker for Cardiovascular Disease?

Canadian journal of cardiology, 2015-10, Vol.31 (10), p.1293-1302

2015

Link zum Volltext

Verfügbarkeit prüfen

Understanding the driving mechanisms of bioprosthetic valve degeneration

Heart (British Cardiac Society), 2024-02, Vol.110 (4), p.223

Wachtell, Kristian

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis

Circulation (New York, N.Y.), 2013-03, Vol.127 (10), p.1149-1156

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Lower On-Treatment Systolic Blood Pressure on the Risk of Atrial Fibrillation in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 2015-08, Vol.66 (2), p.368-373

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy

JACC. Cardiovascular imaging, 2010-06, Vol.3 (6), p.555-562

2010

Link zum Volltext

Verfügbarkeit prüfen

Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients

Circulation. Cardiovascular imaging, 2014-05, Vol.7 (3), p.422-429

2014

Link zum Volltext

Verfügbarkeit prüfen

When to Operate: Severe Aortic Stenosis Is Still a Clinical Enigma

The American journal of cardiology, 2013-11, Vol.112 (9), p.1510-1511

Wachtell, Kristian, MD, PhD, DrMedSci

2013

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation is target organ damage caused by an impaired haemodynamic state

Heart (British Cardiac Society), 2018-08, Vol.104 (15), p.1234

Wachtell, Kristian

2018

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

JAMA : the journal of the American Medical Association, 2006-09, Vol.296 (10), p.1242

2006

Link zum Volltext

Verfügbarkeit prüfen

Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts

Journal of hypertension, 2012-10, Vol.30 (10), p.1928-1936

2012

Link zum Volltext

Verfügbarkeit prüfen

Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study

PloS one, 2015-06, Vol.10 (6), p.e0128987-e0128987

2015

Link zum Volltext

Verfügbarkeit prüfen

Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study

The American journal of cardiology, 2007-04, Vol.99 (7), p.970-973

2007

Link zum Volltext

Verfügbarkeit prüfen

Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial

The American journal of cardiology, 2010-06, Vol.105 (12), p.1802-1808

2010

Link zum Volltext

Verfügbarkeit prüfen

Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis

Heart (British Cardiac Society), 2014-01, Vol.100 (1), p.28-33

2014

Link zum Volltext

Verfügbarkeit prüfen

Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study

Reviews in cardiovascular medicine, 2022-03, Vol.23 (3), p.95-95

2022

Link zum Volltext

Verfügbarkeit prüfen

On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy

Blood pressure, 2020-09, Vol.29 (5), p.319-326

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

The American journal of cardiology, 2015-12, Vol.116 (12), p.1840-1844

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study

International journal of cardiology, 2013-06, Vol.166 (1), p.72-76

2013

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study

Blood pressure, 2019-09, Vol.28 (5), p.317-326

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Cardiac Changes Are Target Organ Damage That Increases Risk of Atrial Fibrillation

Journal of the American College of Cardiology, 2014-05, Vol.63 (19), p.2014-2015

2014

Link zum Volltext

Verfügbarkeit prüfen

N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome

Hypertension (Dallas, Tex. 1979), 2005-10, Vol.46 (4), p.660-666

2005

Link zum Volltext

Verfügbarkeit prüfen

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study

Blood pressure, 2017-06, Vol.26 (3), p.150-155

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(348)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(212)
Humans
(206)
Cardiovascular System & Cardiology
(194)
Male
(166)
Female
(165)
Aged
(157)
Middle Aged
(148)
Hypertension
(122)
Biological And Medical Sciences
(110)
Medical Sciences
(110)
Peripheral Vascular Disease
(105)
Cardiac & Cardiovascular Systems
(101)
Cardiology. Vascular System
(96)
Hypertension - Drug Therapy
(79)
Risk Factors
(78)
Aged, 80 And Over
(75)
Blood And Lymphatic Vessels
(71)
Hypertension - Complications
(68)
Arterial Hypertension. Arterial Hypotension
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension

Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

suPAR: A New Biomarker for Cardiovascular Disease?

Understanding the driving mechanisms of bioprosthetic valve degeneration

Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis

Effect of Lower On-Treatment Systolic Blood Pressure on the Risk of Atrial Fibrillation in Hypertensive Patients

Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy

Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients

When to Operate: Severe Aortic Stenosis Is Still a Clinical Enigma

Atrial fibrillation is target organ damage caused by an impaired haemodynamic state

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts

Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study

Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study

Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial

Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis

Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study

On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study

Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study

Structural and Functional Cardiac Changes Are Target Organ Damage That Increases Risk of Atrial Fibrillation

N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study

Suchergebnisse filtern